scholarly journals Echocardiographic and Electrocardiographic Manifestations of Newly Diagnosed Adult Patients Suffering with Overt Hyperthyroidism

2021 ◽  
Vol 3 (8) ◽  
pp. 53-56
Author(s):  
Rashmi Aggarwal ◽  
Hemant Aggarwal ◽  
Pradeep Chugh ◽  
Vipin VS
2021 ◽  
Author(s):  
Justa Carmen Columbié Regüeiferos ◽  
Taira Teresa Batista Luna ◽  
Soraida Cándida Acosta Brooks ◽  
Maylet Planas Rodriguez ◽  
Larisa Zamora Matamoros ◽  
...  

2017 ◽  
Vol 06 (01) ◽  
Author(s):  
Eddy Jean-Baptiste ◽  
Philippe Larco ◽  
Rodolphe Paul ◽  
Bello Jérôme ◽  
Nancy Charles Larco ◽  
...  

HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 421-422
Author(s):  
A. Rijneveld ◽  
B. van der Holt ◽  
O. de Weerdt ◽  
B. Biemond ◽  
A. van de Loosdrecht ◽  
...  

2019 ◽  
Vol 21 (Supplement_6) ◽  
pp. vi79-vi79
Author(s):  
Matthew Torre ◽  
Mustafa Ascha ◽  
Maya Harary ◽  
Timothy Smith ◽  
Ayal Aizer ◽  
...  

Abstract INTRODUCTION Herein we examine the epidemiology and outcomes of the entire spectrum of intracranial tumors in the contemporary era. METHODS Adult patients (≥20yo) presenting between 2010–2015 where the first evidence of cancer involves an intracranial tumor were queried from the National Cancer Database, which comprises >70% of cancers newly-diagnosed in the U.S. Tumor types were classified by WHO2016 ICD-O3, and stratified by patient characteristics. RESULTS 361,841 adults without a history of cancer presented with intracranial tumors between 2010–2015. Across all ages, these were comprised of 1) brain metastases (BMs; 25%: 29% in males vs. 23% in females); 2) meningiomas (25%: 15% in males, but 34% in females) including atypical (n=4,565) and anaplastic (n=833); 3) diffuse infiltrative gliomas (21%: 26% in males vs. 17% in females), mostly GBMs (14%); followed by 4) sellar (14%), 5) cranial nerve (6%), and PCNSL (3%) tumors. The remaining types each comprised ≤2 % of brain tumors, including mesenchymal non-meningothelial tumors (2%), intracranial ependymal (0.8%), mixed neuronal-glial (0.7%), circumscribed “other astrocytomas” (0.6%, mostly pilocytic astrocytomas n=1,307 and PXAs n=272), CNS embryonal (0.3%), pineal (0.2%), GCTs (0.1%), and choroid plexus (0.1%) tumors. In the 91,686 patients presenting with a BM, the most common primaries were lung adenocarcinoma (39%), lung SmallCC (14%), lung SqCC (8%), breast (8% of females), melanoma (3%), kidney (3%), colorectal (2%), and esophageal (1%). The distributions of brain tumor types differed significantly by age, sex, race/ethnicity, and insurance status. CONCLUSIONS In adult patients where the first manifestation of cancer includes an intracranial tumor, the most common diagnosis is either metastatic disease (predominantly from NSCLC) in males or benign meningiomas in females; but varies substantially by age group. Notably, our results adjust the traditional teaching that half of all new brain masses are BMs, which in fact represent only ~25% of new intracranial masses.


2019 ◽  
Vol 36 (5) ◽  
pp. 870-876
Author(s):  
Sadettin Selçuk Baysal ◽  
Mehmet Has

2017 ◽  
Vol 22 (1) ◽  
pp. 411-418 ◽  
Author(s):  
Rilana Busjan ◽  
Justin Hasenkamp ◽  
Gerhard Schmalz ◽  
Rainer Haak ◽  
Lorenz Trümper ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document